Unique ID issued by UMIN | UMIN000007427 |
---|---|
Receipt number | R000008724 |
Scientific Title | A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma. |
Date of disclosure of the study information | 2012/03/02 |
Last modified on | 2021/09/08 11:28:34 |
A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
Japan |
Hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The purpose of this study is to prospectively assess the efficacy and safety in patients with advanced hepatocellular carcinoma treated with sorafenib.
Safety,Efficacy
The primary outcome of this study is the overall survival time.
Observational
20 | years-old | <= |
90 | years-old | >= |
Male and Female
The patient who can expect survival more than three months.
A case of EOCG performance status 0 or 1.
The patient that an effect of the previous treatment, a side effect are not carried over
A case (inspection within two weeks before registration) that enough main organ (including marrow, a heart, the liver, the kidney) functions are maintained.
More than WBC 2000/mm3
More than 8.5 g/dl of Hb
More than Platelet 50,000/mm3
Less than Child-Pugh score seven points
Total bilirubin. 2 mg/dl or less
There not being the abdominal dropsy that Control is impossible of, hepatic encephalopathy
Is less than Creatinine 1.5 mg/dl; or Creatinine Clearance more than 50ml/min
Ejection fraction more than 45% (heart trouble merger patient)
A PaO2 more than 60 mmHg (chronic lung disease patient)
An infectious disease of the activity (but except the viral hepatitis)
An overlap cancer of the activity
A past of sensitivity to iodocontrast media
A pregnant woman, a nursing girl may be pregnant
The case that the medical attendant judged to be inappropriate as an object of the final examination for reasons of others
(problem cases such as a patient does not hear instructions or the support of the family not being provided)
300
1st name | Masahito |
Middle name | |
Last name | Nakano |
Kurume University School of Medicine
Division of Gastroenterology, Department of Medicine
830-0011
67 Asahi-machi, Kurume
0942-35-3311
nakano_masahito@kurume-u.ac.jp
1st name | Masahito |
Middle name | |
Last name | Nakano |
Kurume University School of Medicine
Division of Gastroenterology, Department of Medicine
830-0011
67 Asahi-machi, Kurume
0942-35-3311
nakano_masahito@kurume-u.ac.jp
Division of Gastroenterology, Department of Medicine
Kurume University School of Medicine
Division of Gastroenterology, Department of Medicine
Kurume University School of Medicine
Other
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine
67 Asahi-machi, Kurume
0942-35-3311
nakano_masahito@kurume-u.ac.jp
NO
2012 | Year | 03 | Month | 02 | Day |
Partially published
Enrolling by invitation
2009 | Year | 05 | Month | 01 | Day |
2010 | Year | 05 | Month | 20 | Day |
2009 | Year | 05 | Month | 01 | Day |
2030 | Year | 03 | Month | 31 | Day |
observing
2012 | Year | 03 | Month | 02 | Day |
2021 | Year | 09 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008724